These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 20171240)
1. The 3 + 3 dose escalation design is not appropriate for antivenom dose finding. Chippaux JP; Boyer L Toxicon; 2010 Jun; 55(7):1408-9; author reply 1410-1. PubMed ID: 20171240 [No Abstract] [Full Text] [Related]
2. A new snake antivenom. Med Lett Drugs Ther; 2001 Jun; 43(1107):55-6. PubMed ID: 11426191 [No Abstract] [Full Text] [Related]
3. Snake antivenom research: the importance of case definition. Isbister GK Emerg Med J; 2005 Jun; 22(6):399-400. PubMed ID: 15911943 [No Abstract] [Full Text] [Related]
4. Efficacy of low-dose snake antivenom in severe neurotoxic snake envenoming. Singh A; Agarwal R Am J Emerg Med; 2008 Nov; 26(9):1058-9. PubMed ID: 19091272 [No Abstract] [Full Text] [Related]
5. Snake and spider antivenin: risks and benefits of therapy. Weisman RS; Lizarralde SS; Thompson V J Fla Med Assoc; 1996 Mar; 83(3):192-5. PubMed ID: 8920051 [No Abstract] [Full Text] [Related]
6. Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria. Abubakar SB; Abubakar IS; Habib AG; Nasidi A; Durfa N; Yusuf PO; Larnyang S; Garnvwa J; Sokomba E; Salako L; Laing GD; Theakston RD; Juszczak E; Alder N; Warrell DA; Toxicon; 2010 Apr; 55(4):719-23. PubMed ID: 19874841 [TBL] [Abstract][Full Text] [Related]
7. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea. Williams DJ; Jensen SD; Nimorakiotakis B; Müller R; Winkel KD Toxicon; 2007 May; 49(6):780-92. PubMed ID: 17210167 [TBL] [Abstract][Full Text] [Related]
8. Notes on the use of antivenom. Warrell DA Ceylon Med J; 1983 Sep; 28(3):186. PubMed ID: 6679809 [No Abstract] [Full Text] [Related]
9. A role of snake antivenom skin test from the allergist's point of view. Klaewsongkram J Acta Trop; 2009 Jan; 109(1):84-5; author reply 86. PubMed ID: 18929526 [No Abstract] [Full Text] [Related]
10. Antivenom dosing in 35 patients with severe brown snake (Pseudonaja) envenoming in Western Australia over 10 years. Yeung JM; Little M; Murray LM; Jelinek GA; Daly FF Med J Aust; 2004 Dec 6-20; 181(11-12):703-5. PubMed ID: 15588174 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of antivenom therapy in Vipera palaestinae bites. Bentur Y; Raikhlin-Eisenkraft B; Galperin M Toxicon; 2004 Jul; 44(1):53-7. PubMed ID: 15225562 [TBL] [Abstract][Full Text] [Related]
12. High rate of immediate systemic hypersensitivity reactions to tiger snake antivenom. Comment. Leong J Med J Aust; 2006 Apr; 184(8):420. PubMed ID: 16646159 [No Abstract] [Full Text] [Related]
13. Randomised control trial on the effective dose of anti-snake venom in cases of snake bite with systemic envenomation. Seth AK; Varma PP; Pakhetra R J Assoc Physicians India; 2000 Jul; 48(7):756. PubMed ID: 11273522 [No Abstract] [Full Text] [Related]
14. Antivenom use in Australia. Premedication, adverse reactions and the use of venom detection kits. Sutherland SK Med J Aust; 1992 Dec 7-21; 157(11-12):734-9. PubMed ID: 1360618 [TBL] [Abstract][Full Text] [Related]